Julie Mb Bradley - 08 Jul 2024 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Reporting relationship: Director
Issuer ticker: GDRX
Reported as of: 08 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jul 2024, 17:27:30 UTC
Prior SEC filing: 10 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Gracye Cheng, Attorney-in-Fact for Julie Bradley

Key filing fact

Julie Mb Bradley filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 10 Jul 2024.

Key facts

This page summarizes Julie Mb Bradley's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jul 2024, 17:27.

Change

Previous filing in this sequence was filed on 10 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +2,464
Change %: +2%
Price: $0.000000
Shares after: 126,117
Date: 08 Jul 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.